Takeda’s Next Wave of Drugs Has Investors Watching Closely
Takeda Pharmaceutical Company Ltd. (NYSE:TAK) reported fourth-quarter sales of $6.98 billion, or 1.094 trillion yen, missing Wall Street estimates of $7.05 billion. The Japanese drugmaker reported adjusted earnings of 28 cents per ADR (89 yen per share), beating analyst es